Derma Sciences
This article was originally published in The Gray Sheet
Executive Summary
Letter of intent to acquire Genetic Laboratorires Wound Care for stock valued at $3.6 mil. is announced May 12. Under the terms of the deal, 0.7 shares of Derma Sciences common stock, which closed at 2-1/8 on May 11, would be exchanged for each of St. Paul-based Genetic Laboratories' 2.4 mil. outstanding shares. The companies expect to sign a definitive agreement by the end of May and close the deal by September....